Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Albany Molecular Research, Inc.    AMRI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ALBANY MOLECULAR RESEARCH,
11/10/15 Q3 2015 Earnings Release (Projected)
02/08/16 FY 2015 Earnings Release (Projected)
05/04/16 Q1 2016 Earnings Release (Projected)
08/02/16 Interim 2016 Earnings Release (Projected)
Past events on ALBANY MOLECULAR RESEARCH,
08/04/15 | 08:30am Interim 2015 Earnings Call
08/04/15 Interim 2015 Earnings Release
07/16/15 | 08:30am Acquisition of Gadea Pharmaceutical Group by Albany Molecular Research, Inc.Call
06/03/15 | 10:00am Annual General Meeting
Upcoming sector events for ALBANY MOLECULAR RESEARCH,
08/30/15 | 03:30am ALNYLAM PHARMACEUTICALS, INC. : European Society of Cardiology Meeting
09/10/15 | 09:10am ISIS PHARMACEUTICALS, INC. : Wells Fargo Health Care Conference
09/18/15 ISIS PHARMACEUTICALS, INC. : Morgan Stanley Global Healthcare Conference
10/20/15 ACTELION LTD : Q3 2015 Earnings Release
Annual publications
Previous yearNext Year
Annual results2012201320142015 (e)2016 (e)
Sales
Million $
Released
Forecast
Spread
227
216
5,0%
247
248
-0,39%
277
280
-1,3%

380

446
Operating income (EBITDA)
Million $
Released
Forecast
Spread
32,4
29,1
11%
48,7
46,5
4,6%
46,0
50,7
-9,3%

68,0

84,6
Operating profit (EBIT)
Million $
Released
Forecast
Spread
15,0
11,6
29%
32,8
30,8
6,5%
27,1
33,8
-20%

44,5

54,3
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread




-3,28
23,3
-114%

12,4

27,5
EPS
 $
Released
Forecast
Spread







0,42

0,95
Announcement Date02/12/201302/12/201402/12/2015

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2014
Q1
2015
Q2
2015
Q3
2015 (e)
Q4
2015 (e)
Sales
Million $
Released
Forecast
Spread
86,6
91,9
-5,8%
81,8
81,5
0,39%
89,5
85,0
5,4%

93,8

102
Operating income (EBITDA)
Million $
Released
Forecast
Spread
16,6
22,8
-27%
14,5
15,0
-3,2%
16,5
15,3
7,8%

15,7

18,7
Operating profit (EBIT)
Million $
Released
Forecast
Spread
10,8
18,5
-41%
9,57
9,00
6,3%
12,1
9,55
26%

9,50

12,6
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
-1,86
12,2
-115%
-2,22
5,05
-144%
2,31
5,35
-57%

5,35

7,00
EPS
 $
Released
Forecast
Spread
-0,06
0,37
-116%
-0,07
0,16
-145%
0,07
0,18
-61%

0,17

0,24
Announcement Date02/12/201505/05/201508/04/2015

© 2015 Thomson Reuters
© 2015 Factset
Advertisement
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise